학술논문

Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition.
Document Type
Article
Source
Journal of Pathology; Feb2023, Vol. 259 Issue 2, p194-204, 11p
Subject
CHECKPOINT kinase 1
DNA repair
GENE expression profiling
BIOMARKERS
CANCER cell proliferation
Language
ISSN
00223417
Abstract
Copyright of Journal of Pathology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)